149 related articles for article (PubMed ID: 10613614)
21. Procarbazine, CCNU and vincristine (PCV) combination chemotherapy for brain tumors.
Brufman G; Halpern J; Sulkes A; Catane R; Biran S
Oncology; 1984; 41(4):239-41. PubMed ID: 6462602
[TBL] [Abstract][Full Text] [Related]
22. Effect of Piperine on the Metabolism and Pharmacokinetics of Carbamazepine in Healthy Volunteers.
Bedada SK; Appani R; Boga PK
Drug Res (Stuttg); 2017 Jan; 67(1):46-51. PubMed ID: 27776366
[TBL] [Abstract][Full Text] [Related]
23. Anticonvulsant usage is associated with an increased risk of procarbazine hypersensitivity reactions in patients with brain tumors.
Lehmann DF; Hurteau TE; Newman N; Coyle TE
Clin Pharmacol Ther; 1997 Aug; 62(2):225-9. PubMed ID: 9284859
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic interactions with felbamate. In vitro-in vivo correlation.
Glue P; Banfield CR; Perhach JL; Mather GG; Racha JK; Levy RH
Clin Pharmacokinet; 1997 Sep; 33(3):214-24. PubMed ID: 9314612
[TBL] [Abstract][Full Text] [Related]
25. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
[TBL] [Abstract][Full Text] [Related]
26. Quantification of the impact of enzyme-inducing antiepileptic drugs on irinotecan pharmacokinetics and SN-38 exposure.
Berg AK; Buckner JC; Galanis E; Jaeckle KA; Ames MM; Reid JM
J Clin Pharmacol; 2015 Nov; 55(11):1303-12. PubMed ID: 25975718
[TBL] [Abstract][Full Text] [Related]
27. Drug interactions between chemotherapeutic regimens and antiepileptics.
Yap KY; Chui WK; Chan A
Clin Ther; 2008 Aug; 30(8):1385-407. PubMed ID: 18803983
[TBL] [Abstract][Full Text] [Related]
28. Triazolam is ineffective in patients taking rifampin.
Villikka K; Kivistö KT; Backman JT; Olkkola KT; Neuvonen PJ
Clin Pharmacol Ther; 1997 Jan; 61(1):8-14. PubMed ID: 9024169
[TBL] [Abstract][Full Text] [Related]
29. Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat.
Panesar SK; Bandiera SM; Abbott FS
Drug Metab Dispos; 1996 Jun; 24(6):619-27. PubMed ID: 8781776
[TBL] [Abstract][Full Text] [Related]
30. Population pharmacokinetics of the BEACOPP polychemotherapy regimen in Hodgkin's lymphoma and its effect on myelotoxicity.
Wilde S; Jetter A; Rietbrock S; Kasel D; Engert A; Josting A; Klimm B; Hempel G; Reif S; Jaehde U; Merkel U; Busse D; Schwab M; Diehl V; Fuhr U
Clin Pharmacokinet; 2007; 46(4):319-33. PubMed ID: 17375983
[TBL] [Abstract][Full Text] [Related]
31. Preliminary evaluation of progestins as inducers of cytochrome P450 3A4 activity in postmenopausal women.
Tsunoda SM; Harris RZ; Mroczkowski PJ; Benet LZ
J Clin Pharmacol; 1998 Dec; 38(12):1137-43. PubMed ID: 11301566
[TBL] [Abstract][Full Text] [Related]
32. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
33. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate.
Battino D; Estienne M; Avanzini G
Clin Pharmacokinet; 1995 Nov; 29(5):341-69. PubMed ID: 8582119
[TBL] [Abstract][Full Text] [Related]
34. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
[TBL] [Abstract][Full Text] [Related]
35. Statin medication in patients treated with antiepileptic drugs in Norway.
Gedde-Dahl A; Devold HM; Molden E
Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):881-5. PubMed ID: 22529023
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic interaction between zolpidem and carbamazepine in healthy volunteers.
Vlase L; Popa A; Neag M; Muntean D; Bâldea I; Leucuţa SE
J Clin Pharmacol; 2011 Aug; 51(8):1233-6. PubMed ID: 21098143
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic characteristics of vincristine sulfate liposomes in patients with advanced solid tumors.
Yan Z; Zhu ZL; Qian ZZ; Hu G; Wang HQ; Liu WH; Cheng G
Acta Pharmacol Sin; 2012 Jun; 33(6):852-8. PubMed ID: 22669119
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and urinary excretion of vincristine sulfate liposomes injection in metastatic melanoma patients.
Bedikian AY; Vardeleon A; Smith T; Campbell S; Namdari R
J Clin Pharmacol; 2006 Jul; 46(7):727-37. PubMed ID: 16809798
[TBL] [Abstract][Full Text] [Related]
39. [Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma].
Bouffet E; Mornex F; Jouvet A; Thiesse P; Mertens P; Helfre S; Sindou M; Bret P
Bull Cancer; 1997 Oct; 84(10):951-6. PubMed ID: 9435796
[TBL] [Abstract][Full Text] [Related]
40. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]